Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01283087
Other study ID # 400229
Secondary ID
Status Completed
Phase N/A
First received January 21, 2011
Last updated November 23, 2017
Start date January 2011
Est. completion date May 2016

Study information

Verified date November 2017
Source Vestre Viken Ringerike Sykehus
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to find out whether patients receiving spinal anesthesia containing lidocaine and sufentanil get transient neurological symptoms.


Recruitment information / eligibility

Status Completed
Enrollment 168
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- adults over the age of seventeen years

Exclusion Criteria:

- patient refuse spinal anesthesia

- spinal anesthesia is contraindicated

- pregnancy

- patient is incapable of giving consent

- diabetes

- neurological disorders

- chronic pain

- chronic use of analgesics

- spinal anesthesia within five days before the actual surgery

Study Design


Locations

Country Name City State
Norway Ringerike Sykehus Hønefoss
Norway Vestre Viken HF Ringerike Sykehus Hønefoss

Sponsors (1)

Lead Sponsor Collaborator
Vestre Viken Ringerike Sykehus

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Primary Symptoms of transient neurological symptoms 5 days